A novel multiple tyrosine-kinase targeted agent to explore the future perspectives of anti-angiogenic therapy for the treatment of multiple solid tumors: cabozantinib.
about
Clinical significance of MET in gastric cancerOckham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancerAngiogenesis Inhibitors for the Treatment of Hepatocellular CarcinomaInhibition of the angiopoietin/Tie2 axis induces immunogenic modulation, which sensitizes human tumor cells to immune attack.c-Met Overexpression in Cervical Cancer, a Prognostic Factor and a Potential Molecular Therapeutic Target.An overview of tyrosine kinase inhibitors for the treatment of epithelial ovarian cancer.Clinical trials of antiangiogenic therapy for hepatocellular carcinoma.Safety of available treatment options for renal cell carcinoma.Development of antibody-based c-Met inhibitors for targeted cancer therapy.An overview of quinoline as a privileged scaffold in cancer drug discovery.Emerging growth factor receptor antagonists for the treatment of advanced melanoma.Synthesis of Functionalized Quinolines through a Reaction of Amides and Alkynes Promoted by Triflic Anhydride/Pyridine.Treatment for Patients With Malignant Pheochromocytomas and Paragangliomas: A Perspective From the Hallmarks of Cancer.Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS.The role of palbociclib in thyroid carcinoma with BRAF mutation
P2860
Q26776190-5052E229-7A5D-4B92-80C7-CB7724653C68Q28067777-435048D7-6D95-4B3F-8626-4454780D9871Q28075305-19A1B924-299B-40AF-ACC5-11D5BB588F41Q36286833-30CC2813-6F74-450C-BA3F-F49FA2B08B00Q36441220-0AA4CE80-A2AC-4AC7-A081-CB1375C9EABBQ38631373-16FC96D6-E208-40CD-AABD-E2EC89AC53BBQ38743040-3E0B0ECC-098D-482A-BAD9-58A3B0F0E077Q38824719-2B3EF141-CB58-4165-A626-A81D2EA47965Q38912279-0636062F-B335-4AFF-937E-EBB326060CD2Q39235281-E439C492-D1D6-4AC4-85B7-318D762C2D71Q39340696-37B245A8-3D95-4D86-8F0E-6B3A4998E1D2Q48103313-8D3CA1BC-CFCB-4049-8198-CA1DDC28B993Q54976476-D25E1C88-925A-4E90-A81E-7043036C85FEQ54978488-4AC6C956-F737-4584-B31B-DDE0D27EF74AQ58805425-4EE4A5BE-F517-4735-AB49-135C5DC4F8BC
P2860
A novel multiple tyrosine-kinase targeted agent to explore the future perspectives of anti-angiogenic therapy for the treatment of multiple solid tumors: cabozantinib.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
A novel multiple tyrosine-kina ...... le solid tumors: cabozantinib.
@en
type
label
A novel multiple tyrosine-kina ...... le solid tumors: cabozantinib.
@en
prefLabel
A novel multiple tyrosine-kina ...... le solid tumors: cabozantinib.
@en
P2093
P1476
A novel multiple tyrosine-kina ...... le solid tumors: cabozantinib.
@en
P2093
Bawneet K Narang
Ravindra K Rawal
Shiva K Rastogi
Subhajit Roy
P356
10.2174/1871520614666140902153840
P577
2014-01-01T00:00:00Z